Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling
- PMID: 26484444
- PMCID: PMC5013537
- DOI: 10.1038/nrgastro.2015.180
Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling
Abstract
Despite some advances in our understanding of the molecular characteristics of pancreatic cancer, much more progress is needed. In a new study, RNA profiling of pancreatic cancers was used to identify gene signatures of tumour cells and stromal cells to help predict patient outcomes.
Comment on
-
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.Nat Genet. 2015 Oct;47(10):1168-78. doi: 10.1038/ng.3398. Epub 2015 Sep 7. Nat Genet. 2015. PMID: 26343385 Free PMC article.
Similar articles
-
Gene signatures from pancreatic cancer tumor and stromal cells predict disease outcome.Nat Genet. 2015 Oct;47(10):1102-3. doi: 10.1038/ng.3408. Nat Genet. 2015. PMID: 26417858
-
Subtyping Pancreatic Cancer.Cancer Cell. 2015 Oct 12;28(4):411-413. doi: 10.1016/j.ccell.2015.09.020. Cancer Cell. 2015. PMID: 26461089
-
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.Nat Genet. 2015 Oct;47(10):1168-78. doi: 10.1038/ng.3398. Epub 2015 Sep 7. Nat Genet. 2015. PMID: 26343385 Free PMC article.
-
Stroma and pancreatic ductal adenocarcinoma: an interaction loop.Biochim Biophys Acta. 2012 Aug;1826(1):170-8. doi: 10.1016/j.bbcan.2012.04.002. Epub 2012 Apr 13. Biochim Biophys Acta. 2012. PMID: 22521638 Review.
-
Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.World J Gastroenterol. 2016 Mar 7;22(9):2678-700. doi: 10.3748/wjg.v22.i9.2678. World J Gastroenterol. 2016. PMID: 26973408 Free PMC article. Review.
Cited by
-
The YAP1-NMU Axis Is Associated with Pancreatic Cancer Progression and Poor Outcome: Identification of a Novel Diagnostic Biomarker and Therapeutic Target.Cancers (Basel). 2019 Sep 30;11(10):1477. doi: 10.3390/cancers11101477. Cancers (Basel). 2019. PMID: 31575084 Free PMC article.
-
Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.Cancer Res. 2021 Nov 15;81(22):5589-5595. doi: 10.1158/0008-5472.CAN-21-1606. Epub 2021 Sep 16. Cancer Res. 2021. PMID: 34531319 Free PMC article. Review.
-
Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?Front Endocrinol (Lausanne). 2019 Jan 8;9:779. doi: 10.3389/fendo.2018.00779. eCollection 2018. Front Endocrinol (Lausanne). 2019. PMID: 30671023 Free PMC article. Review.
References
-
- Rahib L, et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74:2913–2921. - PubMed
-
- Moffitt RA, et al. Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. http://dx.doi.org/10.1038/ng.3398. - DOI - PMC - PubMed
-
- Infante JR, et al. Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma. J. Clin. Oncol. 2007;25:319–325. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical